Retrospective analysis of risks and benefits of trimethoprim/sulfamethoxazole as prophylaxis for Pneumocystis jiroveci pneumonia in patients with dermatologic disease.

Authors :: Moumen M
Andrews LA
Wang Y
Haidari W
Jorizzo JL
Source :: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2023 Jun; Vol. 88 (6), pp. 1392-1393. Date of Electronic Publication: 2023 Feb 15.
Publication Year :: 2023
Abstract: Competing Interests: Conflicts of interest None disclosed.

Subjects :: Humans
Retrospective Studies
Trimethoprim, Sulfamethoxazole Drug Combination adverse effects
Risk Assessment
Pneumocystis carinii
Pneumonia, Pneumocystis prevention & control

Full Text Access

Tools